FDA grants breakthrough device status to Freenome's lung cancer blood test

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. BA
7. RTB
8. AAPL
9. FFAI
10. TRMD

Go back to FDA grants breakthrough device status to Freenome's lung cancer blood test
(NASDAQ: FRNM) Delayed: 17.11 --0 (-0%)
Previous Close $17.11    52 Week High $ 
Open $17.11    52 Week Low $ 
Day High $17.11    P/E N/A 
Day Low $17.11    EPS $ 
Volume 29